Saturday - April 19, 2025
White & Case advises Helix Acquisition Corp. II on its US$949 million business combination with BridgeBio Oncology Therapeutics
March 03, 2025
NEW YORK, March 3 [Category: BizLaw/Legal] -- White and Case, a law firm, issued the following news release:

* * *

White & Case advises Helix Acquisition Corp. II on its US$949 million business combination with BridgeBio Oncology Therapeutics

Global law firm White & Case LLP has advised Helix Acquisition Corp. II (NASDAQ: HXLB), a special purpose acquisition company sponsored by affiliates of Cormorant Asset Management, on its entry into a definiti . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products